{"entity":{"type":"insider","cik":"0001333817","url":"/insider/0001333817","json_url":"/insider/0001333817.json","name":"BAY CITY CAPITAL FUND IV CO INVESMENT FUND LP","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":77,"n_filings":17,"first":"2007-04-30","last":"2020-08-19","span_basis":"filed_date"},"name_variants":[{"name":"BAY CITY CAPITAL FUND IV CO INVESMENT FUND LP","source":"filing","n_filings":17,"first_seen":"2007-04-30","last_seen":"2020-08-19"}],"transactions":[{"id":2208131,"accession":"0000899243-20-022972","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-20-022972","line_url":"/filing/0000899243-20-022972#line-3","is_derivative":false,"issuer_cik":"0001157601","issuer_name":"MADRIGAL PHARMACEUTICALS, INC.","issuer_ticker":"MDGL","issuer_name_source":null,"issuer_url":"/issuer/0001157601","owner_cik":null,"owner_name":"BAY CITY CAPITAL LLC; BAY CITY CAPITAL FUND IV CO INVESMENT FUND LP; Bay City Capital Fund IV, L.P.; Bay City Capital Management IV LLC","owner_display_name":"BAY CITY CAPITAL LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7303.0,"shares_display":"7,303","price_per_share":107.64,"price_display":"107.64","price_state":"stated","total_value":786094.92,"total_display":"786,094.92","total_whole":"786,095","shares_owned_after":42875.0,"shares_owned_after_display":"42,875","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-08-19","filed_date":"2020-08-19","scope":"insider"},{"id":2208127,"accession":"0000899243-20-022972","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-20-022972","line_url":"/filing/0000899243-20-022972#line-2","is_derivative":false,"issuer_cik":"0001157601","issuer_name":"MADRIGAL PHARMACEUTICALS, INC.","issuer_ticker":"MDGL","issuer_name_source":null,"issuer_url":"/issuer/0001157601","owner_cik":null,"owner_name":"BAY CITY CAPITAL LLC; BAY CITY CAPITAL FUND IV CO INVESMENT FUND LP; Bay City Capital Fund IV, L.P.; Bay City Capital Management IV LLC","owner_display_name":"BAY CITY CAPITAL LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10197.0,"shares_display":"10,197","price_per_share":110.03,"price_display":"110.03","price_state":"stated","total_value":1121975.91,"total_display":"1,121,975.91","total_whole":"1,121,976","shares_owned_after":50178.0,"shares_owned_after_display":"50,178","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-08-18","filed_date":"2020-08-19","scope":"insider"},{"id":2208123,"accession":"0000899243-20-022972","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-20-022972","line_url":"/filing/0000899243-20-022972#line-1","is_derivative":false,"issuer_cik":"0001157601","issuer_name":"MADRIGAL PHARMACEUTICALS, INC.","issuer_ticker":"MDGL","issuer_name_source":null,"issuer_url":"/issuer/0001157601","owner_cik":null,"owner_name":"BAY CITY CAPITAL LLC; BAY CITY CAPITAL FUND IV CO INVESMENT FUND LP; Bay City Capital Fund IV, L.P.; Bay City Capital Management IV LLC","owner_display_name":"BAY CITY CAPITAL LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12500.0,"shares_display":"12,500","price_per_share":110.73,"price_display":"110.73","price_state":"stated","total_value":1384125.0,"total_display":"1,384,125.00","total_whole":"1,384,125","shares_owned_after":60375.0,"shares_owned_after_display":"60,375","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-08-17","filed_date":"2020-08-19","scope":"insider"},{"id":8414109,"accession":"0000899243-19-029139","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-19-029139","line_url":"/filing/0000899243-19-029139","is_derivative":false,"issuer_cik":"0001157601","issuer_name":"MADRIGAL PHARMACEUTICALS, INC.","issuer_ticker":"MDGL","issuer_name_source":null,"issuer_url":"/issuer/0001157601","owner_cik":null,"owner_name":"BAY CITY CAPITAL FUND IV CO INVESMENT FUND LP; Bay City Capital Management IV LLC; BAY CITY CAPITAL LLC; Bay City Capital Fund IV, L.P.","owner_display_name":"BAY CITY CAPITAL FUND IV CO INVESMENT FUND LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1200000.0,"shares_display":"1,200,000","price_per_share":105.47,"price_display":"105.47","price_state":"stated","total_value":126564000.0,"total_display":"126,564,000.00","total_whole":"126,564,000","shares_owned_after":4089702.0,"shares_owned_after_display":"4,089,702","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-12-13","filed_date":"2019-12-13","scope":"insider","n_lines":2},{"id":8284162,"accession":"0001181431-15-008441","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-15-008441","line_url":"/filing/0001181431-15-008441","is_derivative":false,"issuer_cik":"0001288452","issuer_name":"NEVRO CORP","issuer_ticker":"NVRO","issuer_name_source":null,"issuer_url":"/issuer/0001288452","owner_cik":null,"owner_name":"Bay City Capital Fund IV, L.P.; BAY CITY CAPITAL FUND IV CO INVESMENT FUND LP; Bay City Capital Management IV LLC; BAY CITY CAPITAL LLC","owner_display_name":"Bay City Capital Fund IV, L.P.","owner_url":null,"role":"Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":491835.0,"shares_display":"491,835","price_per_share":47.94,"price_display":"47.94","price_state":"stated","total_value":23578569.9,"total_display":"23,578,569.90","total_whole":"23,578,570","shares_owned_after":1688976.0,"shares_owned_after_display":"1,688,976","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-06-08","filed_date":"2015-06-17","scope":"insider","n_lines":2},{"id":8843743,"accession":"0001181431-11-050461","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-11-050461","line_url":"/filing/0001181431-11-050461","is_derivative":false,"issuer_cik":"0001288452","issuer_name":"EnteroMedics Inc","issuer_ticker":"ETRM","issuer_name_source":null,"issuer_url":"/issuer/0001288452","owner_cik":null,"owner_name":"BAY CITY CAPITAL FUND IV CO INVESMENT FUND LP; Bay City Capital Management IV LLC; BAY CITY CAPITAL LLC; Bay City Capital Fund IV, L.P.","owner_display_name":"BAY CITY CAPITAL FUND IV CO INVESMENT FUND LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":840000.0,"shares_display":"840,000","price_per_share":1.65,"price_display":"1.65","price_state":"stated","total_value":1386000.0,"total_display":"1,386,000.00","total_whole":"1,386,000","shares_owned_after":4800964.0,"shares_owned_after_display":"4,800,964","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-09-23","filed_date":"2011-09-26","scope":"insider","n_lines":2},{"id":7508525,"accession":"0001181431-10-062284","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001181431-10-062284","line_url":"/filing/0001181431-10-062284","is_derivative":false,"issuer_cik":"0001288452","issuer_name":"EnteroMedics Inc","issuer_ticker":"ETRM","issuer_name_source":null,"issuer_url":"/issuer/0001288452","owner_cik":null,"owner_name":"Bay City Capital Management IV LLC; BAY CITY CAPITAL LLC; Bay City Capital Fund IV, L.P.; BAY CITY CAPITAL FUND IV CO INVESMENT FUND LP","owner_display_name":"Bay City Capital Management IV LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1700000.0,"shares_display":"1,700,000","price_per_share":1.74,"price_display":"1.74","price_state":"stated","total_value":2958000.0,"total_display":"2,958,000.00","total_whole":"2,958,000","shares_owned_after":2386980.0,"shares_owned_after_display":"2,386,980","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-12-14","filed_date":"2010-12-16","scope":"insider","n_lines":2},{"id":5878562,"accession":"0001181431-09-010525","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-09-010525","line_url":"/filing/0001181431-09-010525","is_derivative":false,"issuer_cik":"0001288452","issuer_name":"EnteroMedics Inc","issuer_ticker":"ETRM","issuer_name_source":null,"issuer_url":"/issuer/0001288452","owner_cik":null,"owner_name":"Bay City Capital Fund IV, L.P.; Bay City Capital Management IV LLC; BAY CITY CAPITAL LLC; BAY CITY CAPITAL FUND IV CO INVESMENT FUND LP","owner_display_name":"Bay City Capital Fund IV, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1649485.0,"shares_display":"1,649,485","price_per_share":1.15,"price_display":"1.15","price_state":"stated","total_value":1896907.75,"total_display":"1,896,907.75","total_whole":"1,896,908","shares_owned_after":4337102.0,"shares_owned_after_display":"4,337,102","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-02-19","filed_date":"2009-02-20","scope":"insider","n_lines":2},{"id":3526899,"accession":"0001181431-08-058526","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-08-058526","line_url":"/filing/0001181431-08-058526","is_derivative":false,"issuer_cik":"0001288452","issuer_name":"EnteroMedics Inc","issuer_ticker":"ETRM","issuer_name_source":null,"issuer_url":"/issuer/0001288452","owner_cik":null,"owner_name":"Bay City Capital Fund IV, L.P.; BAY CITY CAPITAL FUND IV CO INVESMENT FUND LP; Bay City Capital Management IV LLC; BAY CITY CAPITAL LLC","owner_display_name":"Bay City Capital Fund IV, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":49600.0,"shares_display":"49,600","price_per_share":1.1,"price_display":"1.10","price_state":"stated","total_value":54560.0,"total_display":"54,560.00","total_whole":"54,560","shares_owned_after":2722421.0,"shares_owned_after_display":"2,722,421","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-10-24","filed_date":"2008-10-28","scope":"insider","n_lines":2},{"id":3146467,"accession":"0001181431-08-027650","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-08-027650","line_url":"/filing/0001181431-08-027650","is_derivative":false,"issuer_cik":"0001288452","issuer_name":"EnteroMedics Inc","issuer_ticker":"ETRM","issuer_name_source":null,"issuer_url":"/issuer/0001288452","owner_cik":null,"owner_name":"Bay City Capital Fund IV, L.P.; Bay City Capital Management IV LLC; BAY CITY CAPITAL LLC; BAY CITY CAPITAL FUND IV CO INVESMENT FUND LP","owner_display_name":"Bay City Capital Fund IV, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":25000.0,"shares_display":"25,000","price_per_share":4.5,"price_display":"4.50","price_state":"stated","total_value":112500.0,"total_display":"112,500.00","total_whole":"112,500","shares_owned_after":2673868.0,"shares_owned_after_display":"2,673,868","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-04-29","filed_date":"2008-04-30","scope":"insider","n_lines":2},{"id":3877057,"accession":"0001181431-08-026875","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-08-026875","line_url":"/filing/0001181431-08-026875","is_derivative":false,"issuer_cik":"0001288452","issuer_name":"EnteroMedics Inc","issuer_ticker":"ETRM","issuer_name_source":null,"issuer_url":"/issuer/0001288452","owner_cik":null,"owner_name":"Bay City Capital Fund IV, L.P.; Bay City Capital Management IV LLC; BAY CITY CAPITAL FUND IV CO INVESMENT FUND LP; BAY CITY CAPITAL LLC","owner_display_name":"Bay City Capital Fund IV, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":50000.0,"shares_display":"50,000","price_per_share":4.5,"price_display":"4.50","price_state":"stated","total_value":225000.0,"total_display":"225,000.00","total_whole":"225,000","shares_owned_after":2649395.0,"shares_owned_after_display":"2,649,395","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-04-24","filed_date":"2008-04-28","scope":"insider","n_lines":2},{"id":3518556,"accession":"0001181431-08-016060","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-08-016060","line_url":"/filing/0001181431-08-016060","is_derivative":false,"issuer_cik":"0001288452","issuer_name":"EnteroMedics Inc","issuer_ticker":"ETRM","issuer_name_source":null,"issuer_url":"/issuer/0001288452","owner_cik":null,"owner_name":"BAY CITY CAPITAL LLC; BAY CITY CAPITAL FUND IV CO INVESMENT FUND LP; Bay City Capital Management IV LLC; Bay City Capital Fund IV, L.P.","owner_display_name":"BAY CITY CAPITAL LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":21000.0,"shares_display":"21,000","price_per_share":8.66,"price_display":"8.66","price_state":"stated","total_value":181860.0,"total_display":"181,860.00","total_whole":"181,860","shares_owned_after":2600450.0,"shares_owned_after_display":"2,600,450","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-02-29","filed_date":"2008-03-04","scope":"insider","n_lines":2},{"id":7076098,"accession":"0001181431-07-070480","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-07-070480","line_url":"/filing/0001181431-07-070480","is_derivative":false,"issuer_cik":"0001288452","issuer_name":"EnteroMedics Inc","issuer_ticker":"ETRM","issuer_name_source":null,"issuer_url":"/issuer/0001288452","owner_cik":null,"owner_name":"BAY CITY CAPITAL FUND IV CO INVESMENT FUND LP; BAY CITY CAPITAL LLC; Bay City Capital Fund IV, L.P.; Bay City Capital Management IV LLC","owner_display_name":"BAY CITY CAPITAL FUND IV CO INVESMENT FUND LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":375000.0,"shares_display":"375,000","price_per_share":8.0,"price_display":"8.00","price_state":"stated","total_value":3000000.0,"total_display":"3,000,000.00","total_whole":"3,000,000","shares_owned_after":367088.0,"shares_owned_after_display":"367,088","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-11-15","filed_date":"2007-11-19","scope":"insider","n_lines":2},{"id":7259091,"accession":"0001181431-07-055376","txn_seq":18,"anchor":"line-18","filing_url":"/filing/0001181431-07-055376","line_url":"/filing/0001181431-07-055376#line-18","is_derivative":false,"issuer_cik":"0000755806","issuer_name":"PONIARD PHARMACEUTICALS, INC.","issuer_ticker":"PARD","issuer_name_source":null,"issuer_url":"/issuer/0000755806","owner_cik":null,"owner_name":"Bay City Capital Management IV LLC; Bay City Capital Fund IV, L.P.; BAY CITY CAPITAL FUND IV CO INVESMENT FUND LP; BAY CITY CAPITAL LLC","owner_display_name":"Bay City Capital Management IV LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":58734.0,"shares_display":"58,734","price_per_share":5.9,"price_display":"5.90","price_state":"stated","total_value":346530.6,"total_display":"346,530.60","total_whole":"346,531","shares_owned_after":4457992.0,"shares_owned_after_display":"4,457,992","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-08-30","filed_date":"2007-08-31","scope":"insider"},{"id":7259089,"accession":"0001181431-07-055376","txn_seq":17,"anchor":"line-17","filing_url":"/filing/0001181431-07-055376","line_url":"/filing/0001181431-07-055376#line-17","is_derivative":false,"issuer_cik":"0000755806","issuer_name":"PONIARD PHARMACEUTICALS, INC.","issuer_ticker":"PARD","issuer_name_source":null,"issuer_url":"/issuer/0000755806","owner_cik":null,"owner_name":"Bay City Capital Management IV LLC; Bay City Capital Fund IV, L.P.; BAY CITY CAPITAL FUND IV CO INVESMENT FUND LP; BAY CITY CAPITAL LLC","owner_display_name":"Bay City Capital Management IV LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":11747.0,"shares_display":"11,747","price_per_share":5.9,"price_display":"5.90","price_state":"stated","total_value":69307.3,"total_display":"69,307.30","total_whole":"69,307","shares_owned_after":891599.0,"shares_owned_after_display":"891,599","ownership_form":"I","is_10b5_1":null,"transaction_date":"2007-08-30","filed_date":"2007-08-31","scope":"insider"},{"id":7259087,"accession":"0001181431-07-055376","txn_seq":16,"anchor":"line-16","filing_url":"/filing/0001181431-07-055376","line_url":"/filing/0001181431-07-055376#line-16","is_derivative":false,"issuer_cik":"0000755806","issuer_name":"PONIARD PHARMACEUTICALS, INC.","issuer_ticker":"PARD","issuer_name_source":null,"issuer_url":"/issuer/0000755806","owner_cik":null,"owner_name":"Bay City Capital Management IV LLC; Bay City Capital Fund IV, L.P.; BAY CITY CAPITAL FUND IV CO INVESMENT FUND LP; BAY CITY CAPITAL LLC","owner_display_name":"Bay City Capital Management IV LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2348.0,"shares_display":"2,348","price_per_share":5.9,"price_display":"5.90","price_state":"stated","total_value":13853.2,"total_display":"13,853.20","total_whole":"13,853","shares_owned_after":178319.0,"shares_owned_after_display":"178,319","ownership_form":"I","is_10b5_1":null,"transaction_date":"2007-08-30","filed_date":"2007-08-31","scope":"insider"},{"id":7259085,"accession":"0001181431-07-055376","txn_seq":15,"anchor":"line-15","filing_url":"/filing/0001181431-07-055376","line_url":"/filing/0001181431-07-055376#line-15","is_derivative":false,"issuer_cik":"0000755806","issuer_name":"PONIARD PHARMACEUTICALS, INC.","issuer_ticker":"PARD","issuer_name_source":null,"issuer_url":"/issuer/0000755806","owner_cik":null,"owner_name":"Bay City Capital Management IV LLC; Bay City Capital Fund IV, L.P.; BAY CITY CAPITAL FUND IV CO INVESMENT FUND LP; BAY CITY CAPITAL LLC","owner_display_name":"Bay City Capital Management IV LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1266.0,"shares_display":"1,266","price_per_share":5.9,"price_display":"5.90","price_state":"stated","total_value":7469.4,"total_display":"7,469.40","total_whole":"7,469","shares_owned_after":96091.0,"shares_owned_after_display":"96,091","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-08-30","filed_date":"2007-08-31","scope":"insider"},{"id":7259083,"accession":"0001181431-07-055376","txn_seq":14,"anchor":"line-14","filing_url":"/filing/0001181431-07-055376","line_url":"/filing/0001181431-07-055376#line-14","is_derivative":false,"issuer_cik":"0000755806","issuer_name":"PONIARD PHARMACEUTICALS, INC.","issuer_ticker":"PARD","issuer_name_source":null,"issuer_url":"/issuer/0000755806","owner_cik":null,"owner_name":"Bay City Capital Management IV LLC; Bay City Capital Fund IV, L.P.; BAY CITY CAPITAL FUND IV CO INVESMENT FUND LP; BAY CITY CAPITAL LLC","owner_display_name":"Bay City Capital Management IV LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":392.0,"shares_display":"392","price_per_share":5.75,"price_display":"5.75","price_state":"stated","total_value":2254.0,"total_display":"2,254.00","total_whole":"2,254","shares_owned_after":4458384.0,"shares_owned_after_display":"4,458,384","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-08-30","filed_date":"2007-08-31","scope":"insider"},{"id":7259082,"accession":"0001181431-07-055376","txn_seq":13,"anchor":"line-13","filing_url":"/filing/0001181431-07-055376","line_url":"/filing/0001181431-07-055376#line-13","is_derivative":false,"issuer_cik":"0000755806","issuer_name":"PONIARD PHARMACEUTICALS, INC.","issuer_ticker":"PARD","issuer_name_source":null,"issuer_url":"/issuer/0000755806","owner_cik":null,"owner_name":"Bay City Capital Management IV LLC; Bay City Capital Fund IV, L.P.; BAY CITY CAPITAL FUND IV CO INVESMENT FUND LP; BAY CITY CAPITAL LLC","owner_display_name":"Bay City Capital Management IV LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":213.0,"shares_display":"213","price_per_share":5.9,"price_display":"5.90","price_state":"stated","total_value":1256.7,"total_display":"1,256.70","total_whole":"1,257","shares_owned_after":16159.0,"shares_owned_after_display":"16,159","ownership_form":"I","is_10b5_1":null,"transaction_date":"2007-08-30","filed_date":"2007-08-31","scope":"insider"},{"id":7259078,"accession":"0001181431-07-055376","txn_seq":12,"anchor":"line-12","filing_url":"/filing/0001181431-07-055376","line_url":"/filing/0001181431-07-055376#line-12","is_derivative":false,"issuer_cik":"0000755806","issuer_name":"PONIARD PHARMACEUTICALS, INC.","issuer_ticker":"PARD","issuer_name_source":null,"issuer_url":"/issuer/0000755806","owner_cik":null,"owner_name":"Bay City Capital Management IV LLC; Bay City Capital Fund IV, L.P.; BAY CITY CAPITAL FUND IV CO INVESMENT FUND LP; BAY CITY CAPITAL LLC","owner_display_name":"Bay City Capital Management IV LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":97.0,"shares_display":"97","price_per_share":5.74,"price_display":"5.74","price_state":"stated","total_value":556.78,"total_display":"556.78","total_whole":"557","shares_owned_after":4458481.0,"shares_owned_after_display":"4,458,481","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-08-30","filed_date":"2007-08-31","scope":"insider"},{"id":7259077,"accession":"0001181431-07-055376","txn_seq":11,"anchor":"line-11","filing_url":"/filing/0001181431-07-055376","line_url":"/filing/0001181431-07-055376#line-11","is_derivative":false,"issuer_cik":"0000755806","issuer_name":"PONIARD PHARMACEUTICALS, INC.","issuer_ticker":"PARD","issuer_name_source":null,"issuer_url":"/issuer/0000755806","owner_cik":null,"owner_name":"Bay City Capital Management IV LLC; Bay City Capital Fund IV, L.P.; BAY CITY CAPITAL FUND IV CO INVESMENT FUND LP; BAY CITY CAPITAL LLC","owner_display_name":"Bay City Capital Management IV LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":78.0,"shares_display":"78","price_per_share":5.75,"price_display":"5.75","price_state":"stated","total_value":448.5,"total_display":"448.50","total_whole":"449","shares_owned_after":891677.0,"shares_owned_after_display":"891,677","ownership_form":"I","is_10b5_1":null,"transaction_date":"2007-08-30","filed_date":"2007-08-31","scope":"insider"},{"id":7259075,"accession":"0001181431-07-055376","txn_seq":10,"anchor":"line-10","filing_url":"/filing/0001181431-07-055376","line_url":"/filing/0001181431-07-055376#line-10","is_derivative":false,"issuer_cik":"0000755806","issuer_name":"PONIARD PHARMACEUTICALS, INC.","issuer_ticker":"PARD","issuer_name_source":null,"issuer_url":"/issuer/0000755806","owner_cik":null,"owner_name":"Bay City Capital Management IV LLC; Bay City Capital Fund IV, L.P.; BAY CITY CAPITAL FUND IV CO INVESMENT FUND LP; BAY CITY CAPITAL LLC","owner_display_name":"Bay City Capital Management IV LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":43.0,"shares_display":"43","price_per_share":5.9,"price_display":"5.90","price_state":"stated","total_value":253.7,"total_display":"253.70","total_whole":"254","shares_owned_after":3232.0,"shares_owned_after_display":"3,232","ownership_form":"I","is_10b5_1":null,"transaction_date":"2007-08-30","filed_date":"2007-08-31","scope":"insider"},{"id":7259073,"accession":"0001181431-07-055376","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0001181431-07-055376","line_url":"/filing/0001181431-07-055376#line-9","is_derivative":false,"issuer_cik":"0000755806","issuer_name":"PONIARD PHARMACEUTICALS, INC.","issuer_ticker":"PARD","issuer_name_source":null,"issuer_url":"/issuer/0000755806","owner_cik":null,"owner_name":"Bay City Capital Management IV LLC; Bay City Capital Fund IV, L.P.; BAY CITY CAPITAL FUND IV CO INVESMENT FUND LP; BAY CITY CAPITAL LLC","owner_display_name":"Bay City Capital Management IV LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20.0,"shares_display":"20","price_per_share":5.74,"price_display":"5.74","price_state":"stated","total_value":114.8,"total_display":"114.80","total_whole":"115","shares_owned_after":891697.0,"shares_owned_after_display":"891,697","ownership_form":"I","is_10b5_1":null,"transaction_date":"2007-08-30","filed_date":"2007-08-31","scope":"insider"},{"id":7259071,"accession":"0001181431-07-055376","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001181431-07-055376","line_url":"/filing/0001181431-07-055376#line-8","is_derivative":false,"issuer_cik":"0000755806","issuer_name":"PONIARD PHARMACEUTICALS, INC.","issuer_ticker":"PARD","issuer_name_source":null,"issuer_url":"/issuer/0000755806","owner_cik":null,"owner_name":"Bay City Capital Management IV LLC; Bay City Capital Fund IV, L.P.; BAY CITY CAPITAL FUND IV CO INVESMENT FUND LP; BAY CITY CAPITAL LLC","owner_display_name":"Bay City Capital Management IV LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":15.0,"shares_display":"15","price_per_share":5.75,"price_display":"5.75","price_state":"stated","total_value":86.25,"total_display":"86.25","total_whole":"86","shares_owned_after":178334.0,"shares_owned_after_display":"178,334","ownership_form":"I","is_10b5_1":null,"transaction_date":"2007-08-30","filed_date":"2007-08-31","scope":"insider"},{"id":7259068,"accession":"0001181431-07-055376","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001181431-07-055376","line_url":"/filing/0001181431-07-055376#line-7","is_derivative":false,"issuer_cik":"0000755806","issuer_name":"PONIARD PHARMACEUTICALS, INC.","issuer_ticker":"PARD","issuer_name_source":null,"issuer_url":"/issuer/0000755806","owner_cik":null,"owner_name":"Bay City Capital Management IV LLC; Bay City Capital Fund IV, L.P.; BAY CITY CAPITAL FUND IV CO INVESMENT FUND LP; BAY CITY CAPITAL LLC","owner_display_name":"Bay City Capital Management IV LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":8.0,"shares_display":"8","price_per_share":5.75,"price_display":"5.75","price_state":"stated","total_value":46.0,"total_display":"46.00","total_whole":"46","shares_owned_after":96099.0,"shares_owned_after_display":"96,099","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-08-30","filed_date":"2007-08-31","scope":"insider"},{"id":7259065,"accession":"0001181431-07-055376","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001181431-07-055376","line_url":"/filing/0001181431-07-055376#line-6","is_derivative":false,"issuer_cik":"0000755806","issuer_name":"PONIARD PHARMACEUTICALS, INC.","issuer_ticker":"PARD","issuer_name_source":null,"issuer_url":"/issuer/0000755806","owner_cik":null,"owner_name":"Bay City Capital Management IV LLC; Bay City Capital Fund IV, L.P.; BAY CITY CAPITAL FUND IV CO INVESMENT FUND LP; BAY CITY CAPITAL LLC","owner_display_name":"Bay City Capital Management IV LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3.0,"shares_display":"3","price_per_share":5.74,"price_display":"5.74","price_state":"stated","total_value":17.22,"total_display":"17.22","total_whole":"17","shares_owned_after":178339.0,"shares_owned_after_display":"178,339","ownership_form":"I","is_10b5_1":null,"transaction_date":"2007-08-30","filed_date":"2007-08-31","scope":"insider"},{"id":7259063,"accession":"0001181431-07-055376","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001181431-07-055376","line_url":"/filing/0001181431-07-055376#line-5","is_derivative":false,"issuer_cik":"0000755806","issuer_name":"PONIARD PHARMACEUTICALS, INC.","issuer_ticker":"PARD","issuer_name_source":null,"issuer_url":"/issuer/0000755806","owner_cik":null,"owner_name":"Bay City Capital Management IV LLC; Bay City Capital Fund IV, L.P.; BAY CITY CAPITAL FUND IV CO INVESMENT FUND LP; BAY CITY CAPITAL LLC","owner_display_name":"Bay City Capital Management IV LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3.0,"shares_display":"3","price_per_share":5.74,"price_display":"5.74","price_state":"stated","total_value":17.22,"total_display":"17.22","total_whole":"17","shares_owned_after":96102.0,"shares_owned_after_display":"96,102","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-08-30","filed_date":"2007-08-31","scope":"insider"},{"id":7259061,"accession":"0001181431-07-055376","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001181431-07-055376","line_url":"/filing/0001181431-07-055376#line-4","is_derivative":false,"issuer_cik":"0000755806","issuer_name":"PONIARD PHARMACEUTICALS, INC.","issuer_ticker":"PARD","issuer_name_source":null,"issuer_url":"/issuer/0000755806","owner_cik":null,"owner_name":"Bay City Capital Management IV LLC; Bay City Capital Fund IV, L.P.; BAY CITY CAPITAL FUND IV CO INVESMENT FUND LP; BAY CITY CAPITAL LLC","owner_display_name":"Bay City Capital Management IV LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1.0,"shares_display":"1","price_per_share":5.75,"price_display":"5.75","price_state":"stated","total_value":5.75,"total_display":"5.75","total_whole":"6","shares_owned_after":16160.0,"shares_owned_after_display":"16,160","ownership_form":"I","is_10b5_1":null,"transaction_date":"2007-08-30","filed_date":"2007-08-31","scope":"insider"},{"id":7259059,"accession":"0001181431-07-055376","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001181431-07-055376","line_url":"/filing/0001181431-07-055376#line-3","is_derivative":false,"issuer_cik":"0000755806","issuer_name":"PONIARD PHARMACEUTICALS, INC.","issuer_ticker":"PARD","issuer_name_source":null,"issuer_url":"/issuer/0000755806","owner_cik":null,"owner_name":"Bay City Capital Management IV LLC; Bay City Capital Fund IV, L.P.; BAY CITY CAPITAL FUND IV CO INVESMENT FUND LP; BAY CITY CAPITAL LLC","owner_display_name":"Bay City Capital Management IV LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1.0,"shares_display":"1","price_per_share":5.74,"price_display":"5.74","price_state":"stated","total_value":5.74,"total_display":"5.74","total_whole":"6","shares_owned_after":16161.0,"shares_owned_after_display":"16,161","ownership_form":"I","is_10b5_1":null,"transaction_date":"2007-08-30","filed_date":"2007-08-31","scope":"insider"},{"id":7259058,"accession":"0001181431-07-055376","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-07-055376","line_url":"/filing/0001181431-07-055376#line-2","is_derivative":false,"issuer_cik":"0000755806","issuer_name":"PONIARD PHARMACEUTICALS, INC.","issuer_ticker":"PARD","issuer_name_source":null,"issuer_url":"/issuer/0000755806","owner_cik":null,"owner_name":"Bay City Capital Management IV LLC; Bay City Capital Fund IV, L.P.; BAY CITY CAPITAL FUND IV CO INVESMENT FUND LP; BAY CITY CAPITAL LLC","owner_display_name":"Bay City Capital Management IV LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":0.0,"shares_display":"0","price_per_share":5.75,"price_display":"5.75","price_state":"stated","total_value":0.0,"total_display":null,"total_whole":null,"shares_owned_after":3232.0,"shares_owned_after_display":"3,232","ownership_form":"I","is_10b5_1":null,"transaction_date":"2007-08-30","filed_date":"2007-08-31","scope":"insider"},{"id":7259055,"accession":"0001181431-07-055376","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-07-055376","line_url":"/filing/0001181431-07-055376#line-1","is_derivative":false,"issuer_cik":"0000755806","issuer_name":"PONIARD PHARMACEUTICALS, INC.","issuer_ticker":"PARD","issuer_name_source":null,"issuer_url":"/issuer/0000755806","owner_cik":null,"owner_name":"Bay City Capital Management IV LLC; Bay City Capital Fund IV, L.P.; BAY CITY CAPITAL FUND IV CO INVESMENT FUND LP; BAY CITY CAPITAL LLC","owner_display_name":"Bay City Capital Management IV LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":0.0,"shares_display":"0","price_per_share":5.74,"price_display":"5.74","price_state":"stated","total_value":0.0,"total_display":null,"total_whole":null,"shares_owned_after":3232.0,"shares_owned_after_display":"3,232","ownership_form":"I","is_10b5_1":null,"transaction_date":"2007-08-30","filed_date":"2007-08-31","scope":"insider"},{"id":7345915,"accession":"0001181431-07-055372","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001181431-07-055372","line_url":"/filing/0001181431-07-055372","is_derivative":false,"issuer_cik":"0000755806","issuer_name":"PONIARD PHARMACEUTICALS, INC.","issuer_ticker":"PARD","issuer_name_source":null,"issuer_url":"/issuer/0000755806","owner_cik":null,"owner_name":"BAY CITY CAPITAL LLC; Bay City Capital Management IV LLC; BAY CITY CAPITAL FUND IV CO INVESMENT FUND LP; Bay City Capital Fund IV, L.P.","owner_display_name":"BAY CITY CAPITAL LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4938.0,"shares_display":"4,938","price_per_share":5.7475,"price_display":"5.75","price_state":"stated","total_value":28381.155,"total_display":"28,381.16","total_whole":"28,381","shares_owned_after":4399258.0,"shares_owned_after_display":"4,399,258","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-08-29","filed_date":"2007-08-31","scope":"insider","n_lines":6},{"id":7100240,"accession":"0000898430-07-003033","txn_seq":12,"anchor":"line-12","filing_url":"/filing/0000898430-07-003033","line_url":"/filing/0000898430-07-003033#line-12","is_derivative":false,"issuer_cik":"0000755806","issuer_name":"PONIARD PHARMACEUTICALS, INC.","issuer_ticker":"PARD","issuer_name_source":null,"issuer_url":"/issuer/0000755806","owner_cik":null,"owner_name":"BAY CITY CAPITAL LLC; Bay City Capital Management IV LLC; BAY CITY CAPITAL FUND IV CO INVESMENT FUND LP; Bay City Capital Fund IV, L.P.","owner_display_name":"BAY CITY CAPITAL LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3622.0,"shares_display":"3,622","price_per_share":5.4838,"price_display":"5.48","price_state":"stated","total_value":19862.3236,"total_display":"19,862.32","total_whole":"19,862","shares_owned_after":4395356.0,"shares_owned_after_display":"4,395,356","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-08-16","filed_date":"2007-08-16","scope":"insider"},{"id":7100238,"accession":"0000898430-07-003033","txn_seq":11,"anchor":"line-11","filing_url":"/filing/0000898430-07-003033","line_url":"/filing/0000898430-07-003033#line-11","is_derivative":false,"issuer_cik":"0000755806","issuer_name":"PONIARD PHARMACEUTICALS, INC.","issuer_ticker":"PARD","issuer_name_source":null,"issuer_url":"/issuer/0000755806","owner_cik":null,"owner_name":"BAY CITY CAPITAL LLC; Bay City Capital Management IV LLC; BAY CITY CAPITAL FUND IV CO INVESMENT FUND LP; Bay City Capital Fund IV, L.P.","owner_display_name":"BAY CITY CAPITAL LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":724.0,"shares_display":"724","price_per_share":5.4838,"price_display":"5.48","price_state":"stated","total_value":3970.2712,"total_display":"3,970.27","total_whole":"3,970","shares_owned_after":879072.0,"shares_owned_after_display":"879,072","ownership_form":"I","is_10b5_1":null,"transaction_date":"2007-08-16","filed_date":"2007-08-16","scope":"insider"},{"id":7100236,"accession":"0000898430-07-003033","txn_seq":10,"anchor":"line-10","filing_url":"/filing/0000898430-07-003033","line_url":"/filing/0000898430-07-003033#line-10","is_derivative":false,"issuer_cik":"0000755806","issuer_name":"PONIARD PHARMACEUTICALS, INC.","issuer_ticker":"PARD","issuer_name_source":null,"issuer_url":"/issuer/0000755806","owner_cik":null,"owner_name":"BAY CITY CAPITAL LLC; Bay City Capital Management IV LLC; BAY CITY CAPITAL FUND IV CO INVESMENT FUND LP; Bay City Capital Fund IV, L.P.","owner_display_name":"BAY CITY CAPITAL LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":145.0,"shares_display":"145","price_per_share":5.4838,"price_display":"5.48","price_state":"stated","total_value":795.151,"total_display":"795.15","total_whole":"795","shares_owned_after":175815.0,"shares_owned_after_display":"175,815","ownership_form":"I","is_10b5_1":null,"transaction_date":"2007-08-16","filed_date":"2007-08-16","scope":"insider"}],"collapsed":true,"next_cursor":"2007-08-16|7100236","ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001157601","name":"MADRIGAL PHARMACEUTICALS, INC.","url":"/issuer/0001157601","role":"Ten percent owner","n_filings":2,"first_seen":"2019-12-13","last_seen":"2020-08-19"},{"type":"issuer","type_label":"ISSUER","cik":"0001444380","name":"NEVRO CORP","url":"/issuer/0001444380","role":"Other","n_filings":1,"first_seen":"2015-06-17","last_seen":"2015-06-17"},{"type":"issuer","type_label":"ISSUER","cik":"0001371217","name":"EnteroMedics Inc","url":"/issuer/0001371217","role":"Ten percent owner","n_filings":8,"first_seen":"2007-11-19","last_seen":"2011-09-26"},{"type":"issuer","type_label":"ISSUER","cik":"0000755806","name":"PONIARD PHARMACEUTICALS, INC.","url":"/issuer/0000755806","role":"Ten percent owner","n_filings":5,"first_seen":"2007-04-30","last_seen":"2007-08-31"},{"type":"issuer","type_label":"ISSUER","cik":"0001003929","name":"VIA Pharmaceuticals, Inc.","url":"/issuer/0001003929","role":"Ten percent owner","n_filings":1,"first_seen":"2007-08-08","last_seen":"2007-08-08"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001333817","retrieved_at":"2026-08-23T07:54:27+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}